MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/s2468-2667(25)00194-x

Медицинская библиотека · The Lancet. Public health · 2025

Changes in use and utilisation patterns of drugs with reported shortages between 2010 and 2024 in Europe and North America: a network cohort study.

Pineda-Moncusí Marta, Rekkas Alexandros, Martínez Pérez Álvaro, Leis Angela, Lopez Gomez Carlos, Fey Eric, Bruninx Erwin, Maljković Filip, Sánchez-Sáez Francisco, Rodeiro-Boliart Jordi, Zsuzsa Kiss Loretta, Franz Michael, Mayer Miguel-Angel, Eleangovan Neva, Pulido Pau Pericàs, Natsiavas Pantelis, Şen Selçuk, Cooper Steven, Reisberg Sulev, Manlik Katrin, Price David Brendan, Moscetti Luca, Merkelbach Manon, Tadrous Mina, Rappoport Nadav, Claire Ravinder, Garcia-Torrens Salvador, Prieto-Alhambra Daniel, Rijnbeek Peter R, Burkard Theresa, Drug Shortages EHDEN Study Group

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Drug shortages can negatively impact patient care. We aimed to estimate the incidence and prevalence of use of medicines with shortages announced by the European Medicines Agency between January, 2013, and September, 2023, and to characterise the users of these drugs.

METHODS

In this multinational network cohort study, we used routinely collected data from 52 databases across 18 European countries and the USA covering primary care, secondary care, health insurance claims, and disease registries. We included all participants with a minimum of 365 days of medical history between 2010 and 2024. We estimated annual incidence rates and period prevalence of use of medicines with a reported shortage (n=16), and their key alternatives (n=41). A reduction of 33% or more in incidence or prevalence after the shortage announcement was considered confirmation of a shortage. Additionally, we analysed changes in utilisation in terms of age, sex, indication, duration, and dosage.

FINDINGS: Eight drugs had a 33% or higher reduction in incidence and nine drugs had a 33% or higher reduction in prevalence. Varenicline and amoxicillin (alone or combined with clavulanate) were the medicines affected in the highest number of countries and databases. Additionally, we observed changes in the indication of alteplase (pulmonary embolism indication increased in hospitals in Finland and Germany during the shortage period) and sarilumab (rheumatoid arthritis indication decreased in databases in the UK, Spain, Finland, and Sweden); and among incident users of sarilumab, a decrease in the cumulative dose was observed in databases in the Netherlands (from 84 mg in 2020 to 28 mg in 2023) and a reduction in treatment duration was observed in databases in Finland (from 104 days in 2020 to 1 day in 2022) and Belgium (from 71 days in 2020 to 30 days in 2022).

INTERPRETATION: This study highlighted changes in incidence and prevalence of use of medicines after shortage announcements, and changes observed in patient care in terms of the indication, duration, or prescribed dose of medicines. Our findings showed that some reductions in use were observed across Europe and the USA, and others differed across countries. More research is needed to reduce the effects of drug shortages globally.

FUNDING: Innovative Medicines Initiative 2 Joint Undertaking.

Для цитирования: Pineda-Moncusí Marta, Rekkas Alexandros, Martínez Pérez Álvaro, Leis Angela, Lopez Gomez Carlos, Fey Eric, Bruninx Erwin, Maljković Filip, Sánchez-Sáez Francisco, Rodeiro-Boliart Jordi, Zsuzsa Kiss Loretta, Franz Michael, Mayer Miguel-Angel, Eleangovan Neva, Pulido Pau Pericàs, Natsiavas Pantelis, Şen Selçuk, Cooper Steven, Reisberg Sulev, Manlik Katrin, Price David Brendan, Moscetti Luca, Merkelbach Manon, Tadrous Mina, Rappoport Nadav, Claire Ravinder, Garcia-Torrens Salvador, Prieto-Alhambra Daniel, Rijnbeek Peter R, Burkard Theresa, Drug Shortages EHDEN Study Group. Changes in use and utilisation patterns of drugs with reported shortages between 2010 and 2024 in Europe and North America: a network cohort study.. The Lancet. Public health. 2025. DOI: 10.1016/s2468-2667(25)00194-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.